Search
Protocol No.: E4512
- Title
- A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fushion Protein
- Principal Investigator
- Almubarak, Mohammed
- Phase
- III
- Age Group
- Adult
- Applicable Disease Site
- Lung Cancer
- Participating Institutions
- Camden Clark Medical Center
- Mary Babb Randolph Cancer Center
- United Hospital Center
- Contacts
- Carla Ross, RN
- Senior Research Nurse
- Phone: +1 304-293-2633
- Email: carla.ross@hsc.wvu.edu
- Karla Schartiger
- Coordinator
- Phone: +1 681-342-1842
- Email: karla.schartiger@wvumedicine.org
- Layla Tannoury
- Clinical Research Specialist
- Phone: +1 304-424-2585
- Email: layla.tannoury@wvumedicine.org